We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov Menu

Effects of Spray and Stretch on Postneedling Soreness and Sensitivity After Dry Needling of a Latent Myofascial Trigger Point.

This study has been completed.
ClinicalTrials.gov Identifier:
First Posted: May 31, 2012
Last Update Posted: September 4, 2013
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
CEU San Pablo University
Pain after dry needling or injection in the muscle is a frequent secondary effect in the treatment of myofascial pain syndrome. In this trial spray and stretch technique is evaluated as a method to reduce this soreness. As well, the characteristics and the different factors that influence in this pain will be described.

Condition Intervention Phase
Pain After Dry Needling Other: Spray and stretch Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Investigator)
Primary Purpose: Treatment

Further study details as provided by CEU San Pablo University:

Primary Outcome Measures:
  • Pain [ Time Frame: 72 hours ]
    Visual analogue scale

Secondary Outcome Measures:
  • Pain [ Time Frame: 48 hours ]
    Pressure pain threshold

  • Psychological factors [ Time Frame: 72 hours after needling ]
    Symptom check list revised. SCL-90-r

Enrollment: 70
Study Start Date: March 2012
Primary Completion Date: April 2013 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Spray and stretch Other: Spray and stretch
Physiotherapeutic technique which consist in stretching the muscle while a cold spray is applied on the skin.
No Intervention: Control


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years to 65 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Subjects presenting latent trigger points in the trapezius muscle

Exclusion Criteria:

  • Subjects with active trigger points or absence of trigger points.
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01608633

CEU San Pablo University
Madrid, Spain, 28668
Sponsors and Collaborators
CEU San Pablo University
  More Information

Responsible Party: CEU San Pablo University
ClinicalTrials.gov Identifier: NCT01608633     History of Changes
Other Study ID Numbers: CEU-001
First Submitted: May 27, 2012
First Posted: May 31, 2012
Last Update Posted: September 4, 2013
Last Verified: September 2013